Identification of apolipoprotein C-III as a potential plasmatic biomarker associated with the resolution of hepatitis C virus infection

Abstract : Understanding the virus-host interactions that lead to approximately 20% of patients with acute Hepatitis C Virus (HCV) infection to viral clearance is probably a key towards the development of more effective treatment and prevention strategies. Acute hepatitis C infection is usually asymptomatic and therefore rarely diagnosed. Nevertheless, HCV nucleic acid testing carried out on all blood donations detects donors who have resolved their HCV infection after seroconver-sion. Here we have used SELDI-TOF-MS technology to compare, at a proteomic level, plasma samples respectively from donors with HCV clearance, from donors with chronic HCV infection and from unexposed healthy donors (n = 15 per group). A candidate marker of about 9.4 kDa was detected as differentially expressed in the three groups. After purification we identified by nanoLC-Q-TOF-MS/MS this candidate marker as Apolipoprotein C-III (ApoC-III). The identification was confirmed by western blot analysis. Levels of ApoC-III were then determined in the 45 plasma samples by immunoturbidimetric assay. ApoC-III was found to be higher in donors who had resolved their HCV infection than in donors with chronic infection, results which were consistent with SELDI-TOF-MS data. ApoC-III is the first reported candidate biomarker in plasma associated with the spontaneous resolution of HCV infection.
Liste complète des métadonnées

Littérature citée [67 références]  Voir  Masquer  Télécharger

https://hal-amu.archives-ouvertes.fr/hal-01662783
Contributeur : Stephane Roche <>
Soumis le : mercredi 13 décembre 2017 - 14:19:07
Dernière modification le : mercredi 7 février 2018 - 10:18:32

Fichier

Molina et al. - 2008 - PROTEOM...
Fichiers produits par l'(les) auteur(s)

Identifiants

Citation

Sonia Molina, Dorothée Missé, Stéphane Roche, Stéphanie Badiou, Jean-Paul Cristol, et al.. Identification of apolipoprotein C-III as a potential plasmatic biomarker associated with the resolution of hepatitis C virus infection. PROTEOMICS - Clinical Applications, Wiley-VCH Verlag, 2008, 2 (5), pp.751 - 761. 〈10.1002/prca.200800020〉. 〈hal-01662783〉

Partager

Métriques

Consultations de la notice

214

Téléchargements de fichiers

19